drugset / Trial / NCT02097043
Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This study is a phase I clinical trial for evaluating the pharmacokinetics and safety/tolerability of DA-7218 in healthy male volunteers.
Timeline
- Start
- 2014-05
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-7218 | Unknown | 200 mg | Oral |
| Subject | DA-7218 | Unknown | 400 mg | Oral |
| Subject | DA-7218 | Unknown | 600 mg | Oral |
Indications
No indication recorded.